Sjögren's syndrome in 2013

Medicine Today

Volumn 14, Issue 6, 2013, Pages 26-35

  Tan, Ju Ann ^a   Rischmueller, Maureen ^b,c  

^a QUEEN ELIZABETH HOSPITAL   (Australia)

^b QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^c UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; ARTIFICIAL TEAR; AZATHIOPRINE; C REACTIVE PROTEIN; CEVIMELINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; ETANERCEPT; HLA DQ ANTIGEN; HLA DR ANTIGEN; HYDROXYCHLOROQUINE; INFLIXIMAB; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; METHOTREXATE; PILOCARPINE; RITUXIMAB;

ANNULAR ERYTHEMA; ANOREXIA; ARTHRALGIA; BRONCHIECTASIS; BRONCHIOLITIS OBLITERANS; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE COURSE; DISEASE PREDISPOSITION; DISEASE SEVERITY; DRY EYE; ERYTHROCYTE SEDIMENTATION RATE; FATIGUE; FEVER; FOLLOW UP; GENETIC ASSOCIATION; GENETIC RISK; GLOMERULONEPHRITIS; INTERSTITIAL CYSTITIS; INTERSTITIAL LUNG DISEASE; KERATOCONJUNCTIVITIS SICCA; KIDNEY TUBULE ACIDOSIS; MALAISE; MYALGIA; NEPHROLITHIASIS; ONSET AGE; PAROTITIS; PERICARDITIS; POEMS SYNDROME; PREVALENCE; PROGNOSIS; PURPURA; QUALITY OF LIFE; RAYNAUD PHENOMENON; REVIEW; SJOEGREN SYNDROME; XEROSTOMIA;

EID: 84881153370     PISSN: 1443430X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Tzioufas AG, Mitsias DI, Moutsopoulos HM. Sjogren syndrome. In: Hochberg MC, Silman AJ, Smolen JS, eds. Rheumatology. 5th ed. Philadelphia, PA: Elsevier/Mosby, 2011. p. 1339-1350.
2. Schein OD, Hochberg MC, Munoz B, et al. Dry eye and dry mouth in the elderly: a population-based assessment. Arch Intern Med 1999; 159: 1359-1363. (Pubitemid 29293598)
3. Ramos-Casals M, Brito-Zeron P, Siso-Amirall A, Bosch X. Primary Sjögren's syndrome. BMJ 2012; 344: e3821.
4. Alamanos Y, Tsifetaki N, Voulgari PV, Venetsanopoulou AI, Siozos C, Drosos AA. Epidemiology of primary Sjögren's syndrome in north-west Greece, 1982-2003. Rheumatology (Oxford) 2006; 45: 187-191. (Pubitemid 43160081)
5. Goransson LG, Haldorsen K, Brun JG, et al. The point prevalence of clinically relevant primary Sjögren's syndrome in two Norwegian counties. Scand J Rheumatol 2011; 40: 221-224.
6. Rischmueller M, Lester S, Chen Z, et al. HLA class II phenotype controls diversification of the autoantibody response in primary Sjögren's syndrome (pSS). Clin Exp Immunol 1998; 111: 365-371. (Pubitemid 28088319)
7. Nossent JC, Rischmueller M, Lester S. Low copy number of the Fc-γ receptor 3B gene FCGR3B is a risk factor for primary Sjogren syndrome. J Rheumatol 2012; 39: 2142-2147.
8. Downie-Doyle S, Bayat N, Rischmueller M, Lester S. Influence of CTLA4 haplotypes on susceptibility and some extranglandular manifestations in primary Sjögren's syndrome. Arthritis Rheum 2006; 54: 2434-2440. (Pubitemid 44205003)
9. Voulgarelis M, Moutsopoulos HM. Malignant lymphoma in primary Sjogren syndrome. Isr Med Assoc J 2001; 3: 761-766. (Pubitemid 34082747)
10. Lester S, McLure C, Williamson J, et al. Epistasis between MHC and the RCAα block in primary Sjögren's syndrome. Ann Rheum Dis 2008; 67: 849-854. (Pubitemid 351829387)
11. Waterman SA, Gordon TP, Rischmueller M. Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjogren syndrome. Arthritis Rheum 2000; 43: 1647-1654. (Pubitemid 30452487)
12. Cai FZJ, Lester S, Lu T, et al. Mild autonomic dysfunction in primary Sjogren syndrome: a controlled study. Arthritis Res Ther 2008; 10: R31.
13. Sutcliffe N, Stoll T, Pyke S, Isenberg DA. Functional disability and end organ damage in patients with systemic lupus erythematosus (SLE), SLE and Sjögren syndrome (SS) and primary SS. J Rheumatol 1998; 25: 63-68. (Pubitemid 28060119)
14. Walker J, Gordon T, Lester S, et al. Increased severity of lower urinary tract symptoms and daytime somnolence in primary Sjögren syndrome. J Rheum 2003; 30: 2406-2412. (Pubitemid 37413901)
15. Hilditch CJ, McEvoy RD, George KE, et al. Upper airway surface tension but not upper airway collapsibility is elevated in primary Sjögren syndrome. Sleep 2008; 31: 367-374. (Pubitemid 351536509)
16. Usmani ZA, Hlavac M, Rischmueller M, et al. Sleep disordered breathing in patients with primary Sjögren syndrome: a group controlled study. Sleep Med 2012; 13: 1066-1070.
17. Newton JL, Frith J, Powell D, et al. Autonomic symptoms are common and are associated with overall symptom burden and disease activity in primary Sjögren syndrome. Ann Rheum Dis 2012; 71: 1973-1979.
18. Akasbi M, Berenguer J, Saiz A, et al. White matter abnormalities in primary Sjögren syndrome. QJM 2012; 105: 433-443.
19. Voulgarelis M, Moutsopoulos HM. Mucosa-associated lymphoid tissue lymphoma in Sjögren syndrome: risks, management, and prognosis. Rheum Dis Clin North Am 2008; 34: 921-933.
20. Solans-Laque R, Lopez-Hernandez A, Bosch-Gil JA, et al. Risk, predictors, and clinical characteristics of lymphoma development in primary Sjögren syndrome. Semin Arthritis Rheum 2011; 41: 415-423.
21. Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjögren syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002; 61: 554-558. (Pubitemid 34539104)
22. Shiboski SC, Shiboski CH, Criswell L, et al. American College of Rheumatology classification criteria for Sjögren syndrome: a data-driven, expert consensus approach in the Sjögren International Collaborative Clinical Alliance cohort. Arthritis Care Res 2012; 64: 475-487.
23. Daniels TE, Whitcher JP. Association of patterns of labial salivary gland inflammation with keratoconjunctivitis sicca. Analysis of 618 patients with suspected Sjögren syndrome. Arthritis Rheum 1994; 37: 869-877.
24. Ramos-Casals M, Tzioufas AG, Stone JH, et al. Treatment of primary Sjögren syndrome: a systematic review. JAMA 2010; 304: 452-460.
25. Vivino FB, Al-Hashimi I, Khan Z, et al. Pilocarpine tablets for treatment of dry mouth and dry eye symptoms in patients with Sjögren syndrome: a randomized, placebo-controlled, fixed-dose, multicenter trial. P92-01 Study Group. Arch Intern Med 1999; 159: 174-181. (Pubitemid 29055106)
26. Papas AS, Sherrer YS, Charney M, et al. Successful treatment of dry mouth and dry eye symptoms in Sjögren syndrome patients with oral pilocarpine: a randomized, placebo-controlled, dose-adjustment study. J Clin Rheumatol 2004; 10: 169-177. (Pubitemid 39079593)
27. Fox RI, Dixon R, Guarrasi V, Krubel S. Treatment of primary Sjögren syndrome with hydroxychloroquine: a retrospective, open-label study. Lupus 1996; 5 Suppl 1: S31-S36.
28. Skopouli FN, Jagiello P, Tsifetaki N, Moutsopoulos HM. Methotrexate in primary Sjögren syndrome. Clin Exp Rheumatol 1996; 14: 555-558.
29. Price EJ, Rigby SP, Clancy U, Venables PJ. A double blind placebo-controlled trial of azathioprine in the treatment of primary Sjögren syndrome. J Rheumatol 1998; 25: 896-899. (Pubitemid 28210551)
30. Meijer JM, Meiners PM, Vissink A, et al. Effectiveness of rituximab treatment in primary Sjögren syndrome: a randomized, double-blind, placebo controlled trial. Arthritis Rheum 2010; 62: 960-968.
31. Dass S, Bowman SJ, Vital EM, et al. Reduction of fatigue in Sjogren syndrome with rituximab: results of a randomised, double-blind, placebo-controlled pilot study. Ann Rheum Dis 2008; 67: 1541-1544.
32. Mekinian A, Ravaud P, Hatron PY, et al. Efficacy of rituximab in primary Sjögren syndrome with peripheral nervous system involvement: results from the AIR registry. Ann Rheum Dis 2012; 71: 84-87.
33. Theander E, Manthorpe R, Jacobsson LT. Mortality and causes of death in primary Sjögren syndrome: a prospective cohort study. Arthritis Rheum 2004; 50: 1262-1269. (Pubitemid 38480838)